| ID | Name | CAS | Data |
MW (g/mol) |
| 20-363-6 |
Acetamide, n-(6-formyl-4-oxo-(3h)-pyrimidin-2-yl)-
|
60656-63-5 |
2 | 181.15 |
| 20-364-5 |
3«alpha»,7«beta»,12«alpha»-Trihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
2 | 639.14 |
| 20-382-5 |
Methyl chol-4-en-3,7,12-trione-24-oate, oxime, TMS
|
|
2 | 676.12 |
| 20-510-2 |
5,8-Dihydro-5,8-ethano-2-phenyl-3-(1-phenyl-5'-tetrazolylthio)-1,4-naphthohydroquinone
|
5831-23-2 |
2 | 440.52 |
| 20-690-3 |
6-Bromo-5-tert-butyldimethylsilyloxy-2,3,6-trideoxy-D-erythro-hexono-1,4-lactone
|
|
2 | 323.30 |
| 20-702-9 |
2-Naphthanilide, 3'-chloro-4-[4-diethylamino-o-tolylimino]-1,4-dihydro-1-oxo-
|
115603-88-8 |
2 | 471.98 |
| 20-778-6 |
Benzofuran-5-propanol, 2,3-dihydro-7-hydroxy-3-hydroxymethyl-2-(4-hydroxy-3-methoxyphenyl), tetrakis-TMS
|
|
2 | 635.11 |
| 20-788-5 |
17«alpha»-Methyl-6«beta»,17«beta»-dihydroxy-1,4-androstadien-3-one, bis(trimethylsilyl)
|
67896-65-5 |
2 | 460.80 |
| 20-858-7 |
2,4,6-tridiphenyl-1,3,5,2,4,6-cyclotrisiloxane
|
|
2 | 366.59 |
| 20-965-8 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)propoxy-
|
|
2 | 282.49 |
| 20-992-8 |
Triazolo[4,5-d]pyrimidine, 3h-v-, 5-amino-7-chloro-3-ethyl-
|
|
2 | 198.62 |
| 20-995-5 |
Benzenepropanoic acid, 4-[(trimethylsilyl)oxy]-«alpha»-[[(trimethylsilyl)oxy]imino]-, trimethylsilyl ester
|
55530-68-2 |
2 | 411.72 |
| 21-166-4 |
Laminaritriose: bD-Glcp(1->3)-bDGlcp(1->3)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 21-197-0 |
2,6-Dideoxy-ribo-hexonic acid, 1,4-lactone, TMS
|
|
2 | 290.51 |
| 21-395-0 |
tert-Butyldimethylsilyl 4-(1-(tert-butyldimethylsilyl)-2,2-dimethylhydrazino)-4-oxobutanoate
|
|
2 | 388.69 |
| 21-448-1 |
3«alpha»,7«beta»,17«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, TMS
|
|
2 | 697.30 |
| 21-468-9 |
Silane, dimethyldi(2,6-dimethylnon-1-en-3-yn-5-yloxy)-
|
|
2 | 388.66 |
| 21-519-2 |
Glycine, n-benzyl-n-[6-chloro-5-(2,2,2-trifluoro-n-methylacetamido)pyrimidin-4-yl]-, ethyl ester
|
|
2 | 430.81 |
| 21-563-3 |
Ribonic acid, 2-C-methyl-2,3,4,5-tetrakis-O-(trimethylsilyl)-, trimethylsilyl ester
|
38166-01-7 |
2 | 541.06 |
| 21-592-1 |
5«alpha»-Androstan-17«alpha»-methyl-3',17«beta»-diol-3,2c-pyrazol, TMS
|
|
2 | 488.85 |
| 21-635-3 |
2H-1,3-Benzoxazine, 6-chloro-3-cyclohexyl-3,4-dihydro-8-methyl-
|
|
2 | 265.78 |
| 21-636-2 |
ent-6«alpha»,7«alpha»,17-tri-(OH)-16«beta»,17-dihydrokaurenonic acid, Me-TMS
|
|
2 | 583.03 |
| 21-710-9 |
3-(3,3,5,5,7,7-Hexamethyl-2,4,6,8,11,14-hexaoxa-3,5,7-trisilapentadec-1-yl)pyridine
|
|
2 | 433.72 |
| 21-780-2 |
Phthalimide, n-[3-(tetrahydro-2-oxo-2h-1,3-oxazin-3-yl)propyl]-
|
23545-35-9 |
2 | 288.30 |
| 21-814-4 |
3,18,20-Trioxo-11«beta»,17«alpha»,21-trihydroxy-4-pregnene, MO-TMS, anti
|
|
2 | 680.11 |
| 21-854-0 |
L-Proline, 1-(tert-butyldimethylsilyl)-5-oxo-, tert-butyldimethylsilyl ester
|
107716-03-0 |
2 | 357.64 |
| 21-958-5 |
5-«alpha»-Pregnan-3-«beta»,11-«beta»-diol-20-one, MO-TMS
|
|
2 | 507.90 |
| 21-966-6 |
1,2,3-Propanetricarboxylic acid, 2-[(trimethylsilyl)oxy]-, tris(trimethylsilyl) ester
|
14330-97-3 |
2 | 480.85 |
| 22-126-7 |
(3S,4S)-4-tert-butyldimethylsilyloxy-1-tert-butoxycarbonyl-3-hydroxyazepane
|
|
2 | 345.55 |
| 22-190-6 |
4H-3,1-benzoxazine-2,4(1h)-dione, 6,7,8-trimethoxy-n-methyl-
|
|
2 | 267.24 |
| 22-291-4 |
6«beta»,7«beta»,16«alpha»,17-tetraOH-kauranoic acid, methyl ester TMS ether
|
|
2 | 671.22 |
| 22-324-7 |
3-«alpha»,5-«beta»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
2 | 639.14 |
| 22-413-8 |
4-Cholenoic acid, 7-.alpha.,12-.alpha.-dihydroxy, methyl ester, TMS
|
|
2 | 548.96 |
| 22-462-4 |
4-Pregnen-3-«beta»,20-«beta»-diol-11-one, MO-TMS
|
|
2 | 505.88 |
| 22-478-7 |
2-Propanol, 3-(6-chloro-9h-purin-9-yl)-1-(n,n-diethylamino)-
|
|
2 | 283.76 |
| 22-525-4 |
7«alpha»,12«alpha»,26-trihydroxy,3-oxy-4-cholestenoate, methyl ester-trimethylsilyl ether
|
|
2 | 765.37 |
| 22-698-3 |
Pyrimidine, 2-amino-4-chloro-5-(p-chlorophenylazo)-6-ethylamino-
|
6316-10-5 |
2 | 311.17 |
| 22-764-9 |
13,14-Dihydro-6,15-diketo-PGF1A, EO-TMS, isomer # 2
|
|
2 | 673.17 |
| 22-796-4 |
tert-Butyldimethylsilyl (E)-3,7-dimethylocta-2,6-dienyl phthalate
|
|
2 | 416.63 |
| 22-819-8 |
Silane, diethyl(2,7-dimethyloct-1-en-3-yn-5-yloxy)pentadecyloxy-
|
|
2 | 464.84 |
| 22-977-3 |
3«alpha»,4«beta»,7«alpha»,12«alpha»-tetrahydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
2 | 727.32 |
| 23-115-8 |
5-«alpha»-Pregnan-11-«beta»-ol-20-one, MO-TMS
|
|
2 | 419.72 |
| 23-346-2 |
3«alpha»,7«beta»,14«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 753.40 |
| 23-417-3 |
5«alpha»-Androstan-3«alpha»-ol-17-one, allyl-DMS
|
|
2 | 486.88 |
| 23-446-1 |
5-«alpha»-Pregnan-3-«alpha»,20-«alpha»-diol-11-one, MO-TMS
|
|
2 | 507.90 |
| 23-467-8 |
1,4-Cyclohexanedicarboxamide, n,n'-bis(2-chloroethyl)-n,n'-dinitroso-, trans-
|
|
2 | 353.21 |
| 23-672-0 |
4-P-methoxyanilino-6-methyl-1,3,3a,7-tetrazaindene
|
91769-08-3 |
2 | 255.28 |
| 23-709-9 |
7«alpha»,26-dihydroxy,3-oxy-4-cholestenoate, methyl ester-trimethylsilyl ether
|
|
2 | 677.19 |
| 23-739-6 |
4-[2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-hydroxy-propyl]-2,6-dimethoxy-phenol, TPS
|
|
2 | 717.13 |
| 23-782-8 |
(3S,4S)-3-Azido-4-tert-butyldimethylsilyloxy-1-tert-butoxycarbonylazepane
|
|
2 | 370.56 |
| 23-852-0 |
Androst-1,4-dien-17.alpha.-methyl-6.beta.,17.beta.-diol-3-one, TMS
|
|
2 | 502.93 |
| 23-954-7 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro
|
|
2 | 150.18 |
| 24-022-0 |
7«alpha»,12«alpha»,26-trihydroxy-4-cholesten-3-one, TMS
|
|
2 | 721.36 |
| 24-049-1 |
5-«alpha»-Pregnan-3-«alpha»,11-«beta»,20-«beta»-triol, TMS
|
|
2 | 553.05 |
| 24-117-5 |
7«alpha»,12«alpha»-dihydroxy-3-oxy-4-chol-24-oate, TMS
|
|
2 | 693.26 |
| 24-159-9 |
16«alpha», 17-H2-OH GA53, methyl ester TMS ether
|
|
2 | 538.86 |
| 24-252-5 |
2-Naphthanilide, 2'-chloro-4-[4-diethylamino-o-tolylimino]-1,4-dihydro-1-oxo-
|
115604-50-7 |
2 | 471.98 |
| 24-329-0 |
3-(tert-Butyldimethylsilyloxy)-1-phenyl-4,5-dihydro-1H-pyrazole
|
|
2 | 276.45 |
| 24-409-1 |
17«alpha»-hydroxy-5«alpha»-androstan-3-one (2-enol), per-TMS
|
|
2 | 434.80 |
| 24-724-1 |
Oxadiazole, 1,2,4-, 5-(dichloromethyl)-3-(5-nitrofuran-2-yl)-
|
5671-14-7 |
2 | 264.02 |
| 24-864-6 |
5-«alpha»-Pregnan-3-«alpha»,20-«beta»-diol-11-one, MO-TMS
|
|
2 | 507.90 |
| 25-046-3 |
tert-Butyl-[2-[2-[2-[2-[2-[2-(tert-butyldimethylsilyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]dimethylsilane
|
|
2 | 510.86 |
| 25-099-5 |
5-«alpha»-Pregnan-11-«beta»,20-«beta»-diol-3-one, MO-TMS
|
|
2 | 507.90 |
| 25-154-3 |
5«beta»-Pregnan-3«alpha»,20«beta»-diol, allyl-DMS
|
|
2 | 502.92 |
| 25-160-6 |
3«alpha»,11«beta»-dihydroxy-5«beta»-androstan-17-one, MO-TMS
|
|
2 | 538.00 |
| 25-174-1 |
1H-[1,2,3]triazole-4-carboxamide, 5-amino-1-(phenylmethyl)-
|
|
2 | 217.23 |
| 25-181-3 |
2-Methyl-5,5-pentamethylene-4-acetyl-1,3,4-oxadiazoline
|
|
2 | 196.25 |
| 25-250-6 |
2,4,6,8-tetramethyl-2,4,6,8-tetra(2-cyanoethyl)-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 452.76 |
| 25-266-9 |
5«alpha»-androst-1-en-1-methyl-17«beta»-oI-3-one, TMS
|
|
2 | 446.81 |
| 25-410-8 |
9H-imidazo[2,1-i]purine, 9-ethyl-7,8-dihydro-
|
93227-13-5 |
2 | 189.22 |
| 25-512-5 |
17-«beta»-Hydroxy-7-«alpha»,17-«alpha»-dimethyl-5-«beta»-androstan-3-one, per-TMS
|
|
2 | 462.86 |
| 25-783-5 |
2-(N,n-di-n-butylamino)-3-(n-pentyl)pyrazine
|
|
2 | 277.46 |
| 25-827-6 |
3,16,17-Trihydroxy-5-abdrosten-11-one, tris-TMS
|
|
2 | 536.97 |
| 25-833-9 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»,17«alpha»,25-triol, DMESI
|
|
2 | 707.34 |
| 26-016-5 |
(3S,4S)-3-tert-Butyldimethylsilyloxy-1-tert-butoxycarbonyl-4-hydroxyazepane
|
|
2 | 345.55 |
| 26-048-0 |
2-(2,2-Dimethylpentoxy)-3,6-di-(n-heptyl) pyrazine
|
116403-03-3 |
2 | 390.65 |
| 26-131-7 |
4,4'-Bis(4-amino-1-naphthylazo)-2,2'-stilbenedisulfonic acid
|
5463-64-9 |
2 | 678.74 |
| 26-154-2 |
Arabinaric acid, 2,3,4-tris-O-(trimethylsilyl)-, bis(trimethylsilyl) ester
|
38165-95-6 |
2 | 541.02 |
| 26-165-0 |
5-Pregnane-11-one-3.alpha.,20.alpha.-diol, TMSO-TMS
|
|
2 | 566.06 |
| 26-324-3 |
5«beta»-pregn-8-ene-3«alpha»,17«alpha»,20«alpha»-triol
|
|
2 | 551.04 |
| 26-356-8 |
Silane, diphenyl(2,2,3,4,4,4-hexafluorobutoxy)nonyloxy-
|
|
2 | 506.60 |
| 26-412-5 |
Pregnan-11-one, 3,17,20,21-tetrakis[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»,20S)-
|
56196-46-4 |
2 | 655.22 |
| 26-474-7 |
Cholanic acid, 3«alpha»,7«beta»,12«alpha»-trihydroxy, Me-TMS
|
|
2 | 639.14 |
| 26-480-0 |
3«alpha»,7«beta»,12«beta»-Trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 639.14 |
| 26-494-5 |
bis(1,3-dichloro-2-propyl)(2,3-dichloro-1-propyl)phosphate
|
|
2 | 430.91 |
| 26-539-5 |
(E)-10-Dodecenoic acid, 9-hydroxy-12-oxo, methyl ester, PFB-oxime, OH-TMS, # 1
|
|
2 | 509.58 |
| 26-667-3 |
1,3,5(10)-Oestratriene-2-methoxy-3,16«alpha»,17«beta»-triol, 3-TBDMS-16,17-HFB
|
|
2 | 824.71 |
| 26-682-6 |
5«beta»-Cholestane-3«alpha»,7«alpha»,12«alpha»,24R,25-pentol, TMS
|
|
2 | 799.55 |
| 26-731-1 |
1, 1'-Thiobis(2-methyl-4-tert-butyldimethylsilyloxy-5-tert-butylbenzene)
|
|
2 | 587.06 |
| 26-804-0 |
12-Oxa-9-dodecenoic acid, 11-hydroxy, PFBO, TMS, methyl ester
|
|
2 | 509.58 |
| 26-833-8 |
2-Amino-6-methyl-4-oxo-1,3,3a,7-tetrazaindene
|
|
2 | 165.16 |
| 26-838-3 |
S-triazolo(2,3-a)pyrimidin-7-ol, 2-trifluoromethyl-5-methyl-
|
116529-17-0 |
2 | 218.14 |
| 26-996-8 |
3,4-Dihydro-3-phenyl-6-(1,1,3,3-tetramethylbutyl)-2h-1,3-benzoxazine
|
|
2 | 323.48 |
| 27-029-0 |
Oxadiazole, 1,2,4-, 3-chloromethyl-5-(5-nitrofuran-2-yl)-
|
|
2 | 229.58 |
| 27-209-0 |
2-(1-Naphthyl-N-trimethylsilyl-carbamoyl)benzoic acid, trimethylsilyl ester
|
|
2 | 435.67 |
| 27-243-2 |
5-«alpha»-Pregnan-3-«alpha»-16-«alpha»,20-«alpha»-triol, TMS
|
|
2 | 553.05 |
| 27-296-4 |
3«alpha»,7«alpha»,12«alpha»-Trihydroxy-5«beta»-cholestanoic acid, MeTMS
|
|
2 | 725.35 |
| 27-313-4 |
5«alpha»-Androstan-3«beta»,17«beta»-diol, allyl-DMS
|
|
2 | 488.89 |
| 27-357-6 |
2H-1,3-Benzoxazine, 6-(1,1-dimethylethyl)-3,4-dihydro-3-phenyl-
|
|
2 | 267.37 |
| 27-460-1 |
3«alpha»,17«beta»-Dihydroxy-5«alpha»-androstan-6-one, TMS
|
|
2 | 450.80 |
|
« Previous Results
Next Results »
|